Literature DB >> 22011931

Novel in vitro-in vivo extrapolation (IVIVE) method to predict hepatic organ clearance in rat.

Ken-ichi Umehara1, Gian Camenisch.   

Abstract

PURPOSE: Drug elimination in the liver consists of uptake, metabolism, biliary excretion, and sinusoidal efflux from the hepatocytes to the blood. We aimed to establish an accurate prediction method for liver clearance in rats, considering these four elimination processes. In vitro assays were combined to achieve improved predictions.
METHODS: In vitro clearances for uptake, metabolism, biliary excretion and sinusoidal efflux were determined for 13 selected compounds with various physicochemical and pharmacokinetic properties. Suspended hepatocytes, liver microsomes and sandwich-cultured hepatocytes were evaluated as in vitro models. Based on the individual processes, in vivo hepatic clearance was calculated. Subsequently, the predicted clearances were compared with the corresponding in vivo values from literature.
RESULTS: Using this in vitro-in vivo extrapolation method good linear correlation was observed between predicted and reported clearances. Linear regression analysis revealed much improved prediction for the novel method (r(2) = 0.928) as compared to parameter analysis using hepatocyte uptake only (r(2) = 0.600), microsomal metabolism only (r(2) = 0.687) or overall hepatobiliary excretion in sandwich-cultured hepatocytes (r(2) = 0.321).
CONCLUSIONS: In this new attempt to predict hepatic elimination under consideration of multiple clearance processes, in vivo hepatic clearances of 13 compounds in rats were well predicted using an IVIVE analysis method based on in vitro assays.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22011931     DOI: 10.1007/s11095-011-0607-2

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  70 in total

1.  Evaluation of the human prediction of clearance from hepatocyte and microsome intrinsic clearance for 52 drug compounds.

Authors:  A-K Sohlenius-Sternbeck; L Afzelius; P Prusis; J Neelissen; J Hoogstraate; J Johansson; E Floby; A Bengtsson; O Gissberg; J Sternbeck; C Petersson
Journal:  Xenobiotica       Date:  2010-09       Impact factor: 1.908

2.  Dose-dependent pharmacokinetics of cyclosporin A in rats: events in tissues.

Authors:  C Tanaka; R Kawai; M Rowland
Journal:  Drug Metab Dispos       Date:  2000-05       Impact factor: 3.922

3.  Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.

Authors:  Franco Lombardo; R Scott Obach; Marina Y Shalaeva; Feng Gao
Journal:  J Med Chem       Date:  2004-02-26       Impact factor: 7.446

4.  Construction of a physiologically based pharmacokinetic model to describe the hepatobiliary excretion process of ligands: quantitative estimation of intracellular diffusion.

Authors:  K Sathirakul; H Suzuki; K Yasuda; M Hanano; Y Sugiyama
Journal:  Biol Pharm Bull       Date:  1993-03       Impact factor: 2.233

5.  Metabolic clearance of furosemide in the rat.

Authors:  J D Wallin; P Ryals; N Kaplowitz
Journal:  J Pharmacol Exp Ther       Date:  1977-01       Impact factor: 4.030

6.  Biliary excretion and enterohepatic circulation of two beta-adrenergic blocking drugs, exaprolol and propranolol, in rats.

Authors:  O Tomcíková; S Bezek; M Durisová; V Faberová; M Zemánek; T Trnovec
Journal:  Biopharm Drug Dispos       Date:  1984 Apr-Jun       Impact factor: 1.627

7.  Ketoconazole and the modulation of multidrug resistance-mediated transport in Caco-2 and MDCKII-MDR1 drug transport models.

Authors:  Y Fan; R Rodriguez-Proteau
Journal:  Xenobiotica       Date:  2008-02       Impact factor: 1.908

8.  Distribution of quinidine in rats with carbon tetrachloride-intoxicated hepatic disease.

Authors:  N Sugihara; K Furuno; N Kita; T Murakami; N Yata
Journal:  J Pharmacobiodyn       Date:  1992-04

9.  Determination of hepatic blood flow in the rat using sequential infusions of indocyanine green or galactose.

Authors:  G M Pollack; K L Brouwer; K B Demby; J A Jones
Journal:  Drug Metab Dispos       Date:  1990 Mar-Apr       Impact factor: 3.922

10.  Physiologically based pharmacokinetic modeling to predict transporter-mediated clearance and distribution of pravastatin in humans.

Authors:  Takao Watanabe; Hiroyuki Kusuhara; Kazuya Maeda; Yoshihisa Shitara; Yuichi Sugiyama
Journal:  J Pharmacol Exp Ther       Date:  2008-11-10       Impact factor: 4.030

View more
  9 in total

1.  Microengineered cell and tissue systems for drug screening and toxicology applications: Evolution of in-vitro liver technologies.

Authors:  O B Usta; W J McCarty; S Bale; M Hegde; R Jindal; A Bhushan; I Golberg; M L Yarmush
Journal:  Technology (Singap World Sci)       Date:  2015-03

Review 2.  Drug Disposition Classification Systems in Discovery and Development: A Comparative Review of the BDDCS, ECCS and ECCCS Concepts.

Authors:  Gian P Camenisch
Journal:  Pharm Res       Date:  2016-07-20       Impact factor: 4.200

Review 3.  ITC recommendations for transporter kinetic parameter estimation and translational modeling of transport-mediated PK and DDIs in humans.

Authors:  M J Zamek-Gliszczynski; C A Lee; A Poirier; J Bentz; X Chu; H Ellens; T Ishikawa; M Jamei; J C Kalvass; S Nagar; K S Pang; K Korzekwa; P W Swaan; M E Taub; P Zhao; A Galetin
Journal:  Clin Pharmacol Ther       Date:  2013-02-25       Impact factor: 6.875

Review 4.  Successful and Unsuccessful Prediction of Human Hepatic Clearance for Lead Optimization.

Authors:  Jasleen K Sodhi; Leslie Z Benet
Journal:  J Med Chem       Date:  2021-03-25       Impact factor: 7.446

5.  An overview of the evidence and mechanisms of herb-drug interactions.

Authors:  Pius S Fasinu; Patrick J Bouic; Bernd Rosenkranz
Journal:  Front Pharmacol       Date:  2012-04-30       Impact factor: 5.810

6.  Recent developments in in vitro and in vivo models for improved translation of preclinical pharmacokinetics and pharmacodynamics data.

Authors:  Jaydeep Yadav; Mehdi El Hassani; Jasleen Sodhi; Volker M Lauschke; Jessica H Hartman; Laura E Russell
Journal:  Drug Metab Rev       Date:  2021-05-25       Impact factor: 6.984

Review 7.  A Critical Perspective on 3D Liver Models for Drug Metabolism and Toxicology Studies.

Authors:  Ana S Serras; Joana S Rodrigues; Madalena Cipriano; Armanda V Rodrigues; Nuno G Oliveira; Joana P Miranda
Journal:  Front Cell Dev Biol       Date:  2021-02-22

8.  RAID: Regression Analysis-Based Inductive DNA Microarray for Precise Read-Across.

Authors:  Yuto Amano; Masayuki Yamane; Hiroshi Honda
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988

9.  Rate-Determining and Rate-Limiting Steps in the Clearance and Excretion of a Potent and Selective p21-Activated Kinase Inhibitor: A Case Study of Rapid Hepatic Uptake and Slow Elimination in Rat.

Authors:  Peter W Fan; Jacob Z Chen; M Allan Jaochico; Hank La; Ning Liu; Teresa Mulder; Robert T Cass; Matthew Durk; Kirsten Messick; Nicole Valle; Shannon Liu; Wendy Lee; James J Crawford; Joachim Rudolf; Lesley J Murray; S Cyrus Khojasteh; Matthew Wright
Journal:  Drug Metab Lett       Date:  2016
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.